BFC Planning’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.9K Sell
350
-490
-58% -$44.9K ﹤0.01% 1741
2026
Q2
$80.7K Hold
840
– – ﹤0.01% 1323
2026
Q1
$31.1K Buy
840
+350
+71% +$11.2K ﹤0.01% 1521
2025
Q4
$9.9K Hold
490
– – ﹤0.01% 2084
2025
Q3
$14.8K Hold
490
– – ﹤0.01% 1723
2025
Q2
$6.34K Hold
490
– – ﹤0.01% 1972
2025
Q1
$3.57K Hold
490
– – ﹤0.01% 2141
2024
Q4
$8.15K Hold
490
– – ﹤0.01% 1844
2024
Q3
$6.3K Buy
+490
New +$7.08K ﹤0.01% 1933

Other funds holding AEHR

BFC Planning's AEHR Position: Q3 2026 in Review

BFC Planning reduced its Aehr Test Systems (AEHR) stake by 58% in Q3 2026, selling an estimated $44.9K and leaving 350 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

BFC Planning first reported a position in AEHR in Q3 2024 and has held it in 9 quarters since. The position peaked at $80.7K in Q2 2026. 234 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • BFC Planning held 350 shares of Aehr Test Systems worth $34.9K as of Q3 2026.
  • BFC Planning sold 490 Aehr Test Systems shares in Q3 2026, an estimated $44.9K.
  • Aehr Test Systems made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1741 holding.
  • BFC Planning first reported a position in Aehr Test Systems in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Aehr Test Systems position peaked at $80.7K in Q2 2026.
  • 234 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.